Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axcelead Drug Discovery Partners
Fujisawa, Kanagawa, Japanaxcelead-us.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Axcelead Drug Discovery Partners enables discovery and candidate optimization across multiple modalities, particularly small molecules, antibody-drug conjugates, and targeted protein degraders, with extensive partnerships but does not sponsor its own clinical trials directly.
- Therapeutic areas
- OncologyNeurologyImmunology
- Modalities
- Small moleculeAntibody-drug conjugateCell therapyProteinRNA therapyPeptidesAntibodyTargeted protein degrader
- Industry
- Drug Discovery Services
02
Partnerships
Nissan ChemicalSuperluminal MedicinesLOTTE BIOLOGICSKanaph TherapeuticsAstellas Pharma
Beyond the preview
Go deeper on Axcelead Drug Discovery Partners.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Axcelead Drug Discovery Partners.